GHRP-2
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Price range: $34.99 through $48.99
- Official retailer
- Quality guaranteed
- Within 2 Days Delivery
- 99% Purified
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide belonging to the class ofย growth hormone secretagogues. It is widely studied in laboratory environments for its interaction with theย growth hormone secretagogue receptor (GHS-R)ย and its ability to stimulate signaling pathways associated with endogenous growth hormone release.
GHRP-2 functions as a ghrelin receptor agonist and has been used extensively in experimental models examiningย endocrine signaling, metabolic regulation, and neuroendocrine pathway interactions. Because of its receptor activity, it has become a valuable tool in research exploring hormone secretion patterns and feedback mechanisms within the hypothalamic-pituitary axis.
In controlled laboratory studies, GHRP-2 has been used to investigate:
- Growth hormone secretion models
โข Ghrelin receptor signaling pathways
โข Endocrine feedback regulation
โข Metabolic pathway interaction with hormonal signaling
โข Appetite-associated signaling research
Its relatively short peptide sequence and well-characterized receptor activity make it a commonly studied compound in experimental endocrine models.
Product Details
Form: Lyophilized peptide powder
Peptide Class: Hexapeptide growth hormone secretagogue
Purity: โฅ99% (analytically verified)
CAS Number: 158861-67-7
Peptide ID: LP-G2-15
Certificate of Analysis: Available upon request
Intended Use: Laboratory research only
GHRP-2 acts primarily through activation of theย growth hormone secretagogue receptor (GHS-R1a), a receptor also targeted by the endogenous hormone ghrelin.
When GHRP-2 binds to this receptor in experimental models, it can initiate signaling cascades associated with growth hormone release from the anterior pituitary. This receptor interaction also engages multiple intracellular signaling pathways involved in endocrine regulation.
Ghrelin Receptor Activation
GHRP-2 functions as an agonist of the GHS-R receptor, a receptor found in the hypothalamus and pituitary. Activation of this receptor in laboratory models can stimulate pathways involved in hormone secretion.
Endocrine Signaling Pathways
Research models show that GHRP-2 interacts with signaling systems that regulate hormone release, including pathways related to hypothalamic and pituitary communication.
Metabolic Signaling Research
Because growth hormone plays an important role in metabolic regulation, GHRP-2 has also been studied in laboratory environments examining metabolic pathway signaling and endocrine-metabolic interactions.
Appetite Signaling Models
Ghrelin receptor agonists such as GHRP-2 have also been studied in research involving appetite signaling pathways and energy regulation models.
These mechanistic properties make GHRP-2 useful in controlled experimental settings investigating hormone signaling networks.
GHRP-2 is commonly utilized in laboratory studies investigating:
- Growth hormone secretion models
โข Hypothalamic-pituitary axis research
โข Ghrelin receptor signaling pathways
โข Metabolic hormone interaction studies
โข Appetite signaling mechanisms
โข Neuroendocrine pathway investigation
Researchers are responsible for designing experimental protocols and ensuring compliance with applicable laboratory regulations.
GHRP-2 is aย synthetic hexapeptide, meaning it contains six amino acids arranged in a specific sequence designed to interact with the growth hormone secretagogue receptor.
Its molecular structure allows it to mimic certain aspects of ghrelin receptor activation, enabling researchers to investigate receptor-mediated signaling responses in experimental models.
The peptideโs compact structure contributes to its stability and usefulness in laboratory endocrine research.
Form: Lyophilized powder
Purity: โฅ99% analytical verification
Peptide Class: Growth hormone secretagogue hexapeptide
CAS Number: 158861-67-7
Peptide ID: LP-G2-15
Packaging: Sterile research vial
Storage: Refrigerated (2โ8ยฐC)
Each batch of GHRP-2 undergoes analytical verification to ensure research-grade quality and consistency.
Quality verification procedures may include:
- High-Performance Liquid Chromatography (HPLC) purity testing
โข Identity confirmation analysis
โข Batch traceability documentation
โข Controlled lyophilization procedures
โข Sterile packaging verification
Certificates of Analysis are available upon request.
GHRP-2 is supplied as aย lyophilized powderย intended for laboratory research environments.
Recommended storage conditions:
- Store refrigerated atย 2โ8ยฐC
โข Protect from direct light exposure
โข Avoid repeated temperature cycling
โข Handle using proper laboratory techniques
The peptide is supplied dry and is not pre-reconstituted.
This product is intended strictly forย laboratory research purposes only.
Not for human consumption.
Not for veterinary use.
Not for therapeutic or diagnostic applications.
By purchasing this product, the buyer acknowledges compliance with all applicable laws and research regulations.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide growth hormone secretagogue studied in laboratory environments for its interaction with ghrelin receptors and endocrine signaling pathways.
GHRP-2 belongs to a class of peptides known asย growth hormone secretagogues, which are compounds investigated for their ability to stimulate growth hormone signaling pathways in experimental models.
Our GHRP-2 is supplied as aย sterile lyophilized powderย intended for laboratory research applications.
The CAS number for GHRP-2 isย 158861-67-7.
No. GHRP-2 is intended strictly forย laboratory research purposes only.
Store GHRP-2 refrigerated atย 2โ8ยฐC, protected from light, and handled according to laboratory best practices.
Each batch is analytically verified toย โฅ99% purityย and supported by batch documentation and COA availability.
Certificates of Analysis can be requested by contacting support and referencing your order information.
GHRP-2 Dosage Protocol (5 mg & 10 mg Vials)
Quickstart Highlights
GHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus[1][2]. It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency[3]. This educational protocol presents a onceโdaily subcutaneous approach using practical dilutions for clear insulinโsyringe measurements.
- Multiple vial sizes: Choose from 5 mg or 10 mg vials to match your protocol needs.
- Daily dose range: 100โ300 mcg (0.1โ0.3 mg) once daily (gradual escalation protocol).
- Convenient dosing: Each vial size has optimized reconstitution for easy insulin syringe measurements.
- Storage: Lyophilized: freeze at โ20 ยฐC (โ4 ยฐF); after reconstitution, refrigerate at 2โ8 ยฐC (35.6โ46.4 ยฐF) and use within 28 days.
Dosing & Reconstitution Guide
Educational guide for all vial sizes - choose your optimal concentration
5 mg Vial Protocol (3 mL = ~1.67 mg/mL)
| Week | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Weeks 1โ2 | 100 mcg (0.1 mg) | 6 units (0.06 mL) |
| Weeks 3โ4 | 150 mcg (0.15 mg) | 9 units (0.09 mL) |
| Weeks 5โ8 | 200 mcg (0.2 mg) | 12 units (0.12 mL) |
| Weeks 9โ12 | 200 mcg (0.2 mg) | 12 units (0.12 mL) |
| Weeks 13โ16 | 200 mcg (0.2 mg) | 12 units (0.12 mL) |
Reconstitution: Add 3.0 mL bacteriostatic water โ ~1.67 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ 16.7 mcg on a Uโ100 insulin syringe. Ideal for low-volume daily dosing. For โค10-unit (โค0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
10 mg Vial Protocol (3 mL = ~3.33 mg/mL)
| Week | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Weeks 1โ2 | 100 mcg (0.1 mg) | 3 units (0.03 mL) |
| Weeks 3โ4 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) |
| Weeks 5โ8 | 200 mcg (0.2 mg) | 6 units (0.06 mL) |
| Weeks 9โ12 | 200 mcg (0.2 mg) | 6 units (0.06 mL) |
| Weeks 13โ16 | 200 mcg (0.2 mg) | 6 units (0.06 mL) |
Reconstitution: Add 3.0 mL bacteriostatic water โ ~3.33 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ 33.3 mcg on a Uโ100 insulin syringe. More concentrated for smaller injection volumes. For โค10-unit (โค0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps (All Vial Sizes)
- Draw appropriate volume of bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall to minimize foaming; avoid shaking.
- Gently swirl or roll the vial until the powder is fully dissolved.
- Label the vial with the reconstitution date and refrigerate at 2โ8 ยฐC (35.6โ46.4 ยฐF), protected from light.
- Use reconstituted solution within 28 days for maximum potency and safety[8].
Supplies Needed
Plan based on an 8โ16 week daily protocol with gradual titration.
- Peptide Vials (GHRP-2): Choose your preferred vial size (5 mg or 10 mg).
- Insulin Syringes (Uโ100, 1 mL): For โค10-unit doses, 30โ or 50โunit syringes recommended for precision.
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
- 8 weeks (5 mg: 2 vials / 10 mg: 1 vial): 6 mL or 3 mL โ 1 ร 10 mL bottle
- 12 weeks (5 mg: 4 vials / 10 mg: 2 vials): 12 mL or 6 mL โ 2 ร 10 mL or 1 ร 10 mL bottles
- 16 weeks (5 mg: 5 vials / 10 mg: 3 vials): 15 mL or 9 mL โ 2 ร 10 mL or 1 ร 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs โ recommend 2 ร 100โcount boxes
- 12 weeks: 168 swabs โ recommend 2 ร 100โcount boxes
- 16 weeks: 224 swabs โ recommend 3 ร 100โcount boxes
- Sharps Container: 1โquart container holds ~100 syringes; 2โquart for longer protocols.
Protocol Overview
Concise summary of the onceโdaily regimen.
- Goal: Stimulate endogenous growth hormone secretion through ghrelin receptor activation[1].
- Schedule: Daily subcutaneous injections for 8โ12 weeks (extend to 16 weeks if desired).
- Dose Range: 100โ300 mcg daily with gradual titration; higher doses show dose-dependent responses but may offer limited added benefit with routine use[4].
- Vial Options: 5 mg or 10 mg vials with optimized reconstitution for each size.
- Storage: Lyophilized frozen at โ20 ยฐC (โ4 ยฐF); reconstituted refrigerated at 2โ8 ยฐC (35.6โ46.4 ยฐF); use within 28 days.
Dosing Protocol
Suggested daily titration approach based on clinical studies[2][3][4].
- Weeks 1โ2: 100 mcg once daily to establish baseline tolerance.
- Weeks 3โ4: 150 mcg once daily to enhance GH response if well tolerated.
- Weeks 5โ16: 200 mcg once daily for maximal effect in most research scenarios; advanced researchers may optionally increase to 250โ300 mcg.
- Frequency: Once per day (subcutaneous); evening administration may align with nocturnal GH rhythms.
- Cycle Length: 8โ16 weeks; some attenuation may occur in first 1โ2 weeks but response stabilizes with continued dosing[3].
Storage Instructions
Proper storage preserves peptide quality and efficacy[8][9].
- Lyophilized (powder): Store at โ20 ยฐC (โ4 ยฐF) in dry, dark conditions; stable at room temperature for short periods but freezer storage maximizes shelf life[8].
- Reconstituted (solution): Refrigerate at 2โ8 ยฐC (35.6โ46.4 ยฐF) and do not freeze; use within 28 days for maximum potency[9].
- Shelf life: Use reconstituted solution within 28 days; the benzyl alcohol in bacteriostatic water inhibits bacterial growth but solutions should still be discarded after approximately 4 weeks.
- Allow vials to reach room temperature before opening to minimize condensation uptake. Always protect from light and heat.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each injection; dispose in a proper sharps container[10].
- Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and avoid lipodystrophy[13].
- Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis[3]; once-daily administration avoids this issue.
- Multiple daily injections (2โ3ร) have been explored but require strict adherence and may offer limited added benefit[5][6].
- Document daily dose and site rotation to maintain consistency.
- A 5โdaysโon/2โdaysโoff schedule may help maintain GH response sensitivity over long protocols[7].
How This Works
GHRP-2 is a synthetic growth hormone secretagogue that binds to and activates ghrelin (GHS-R1a) receptors[1]. By binding to receptors in both the pituitary and hypothalamus, it triggers robust, pulsatile GH release that mimics natural secretion patterns[2]. Clinical studies have demonstrated that even a single 100 mcg subcutaneous dose can raise GH levels severalโfold above baseline[4]. When administered consistently, GHRP-2 can elevate IGFโ1 levels over weeks to months (~50% increase reported in some studies)[5]. However, the GH response may attenuate with continuous daily use (tachyphylaxis), which is why titration strategies and periodic breaks are often incorporated[4][7]. The peptide has been well tolerated in clinical trials with no significant adverse effects or toxicity reported at these dosage ranges[2][7].
Potential Benefits & Side Effects
Observations from clinical and preclinical literature[1][2][3][4][5][6][7].
Potential Benefits:
- Potent GH stimulation: Robust, pulsatile release without suppressing natural production[1].
- IGFโ1 elevation: Sustained administration can significantly increase IGFโ1 levels[5].
- Clinical diagnostic use: Used as a diagnostic tool for GH deficiency evaluation[3].
- Combination therapy: In combination with GHRH analogs, can further amplify GH/IGFโ1 axis[5][6].
- Generally well tolerated: Placebo-like safety profile in clinical studies[7].
Potential Side Effects:
- Increased appetite (most common): Ghrelinโmimetic action, especially shortly after injection[1].
- Injectionโsite reactions: Mild redness, irritation (generally transient).
- Transient effects: Mild flushing, warmth, or tingling.
- Possible mild hormonal increases: Cortisol and prolactin at higher doses[6].
- Response attenuation: Tachyphylaxis with continuous daily dosing[4].
- High-dose effects: Water retention or joint stiffness with prolonged highโdose use (โฅ300 mcg/day).
Lifestyle Factors
Complementary strategies for optimal outcomes.
- Administer on an empty stomach or before sleep to optimize GH pulse amplitude.
- Maintain adequate protein intake and balanced nutrition to support the anabolic effects of elevated GH.
- Combine resistance training and aerobic activity to support body composition benefits.
- Prioritize 7โ9 hours of quality sleep to synergize with natural nocturnal GH secretion.
- Manage stress effectively, as elevated cortisol can blunt GH response.
- Stay well hydrated to support metabolic processes.
Injection Technique
General subcutaneous guidance from clinical bestโpractice resources[10][11][12].
- Clean the vial rubber stopper and chosen skin site with separate alcohol swabs; allow both to dry completely before proceeding[11].
- Use a fine insulin syringe (typically 29โ31 gauge, 0.5โinch needle). For โค10โunit doses, 30โ or 50โunit syringes improve readability.
- Pinch a fold of skin (abdomen, thigh, or outer upper arm); insert needle at a 45โ90ยฐ angle into subcutaneous tissue (fatty layer, not muscle)[10][12]. (Use 90ยฐ angle if ample fatty tissue; 45ยฐ for leaner individuals.)
- Do not aspirate (pull back the plunger) when giving a subcutaneous injection โ aspiration is unnecessary and can cause tissue trauma[10].
- Inject the solution slowly and steadily; wait a few seconds after injection before withdrawing the needle to ensure complete delivery and minimize leakage.
- Withdraw the needle and apply light pressure with a clean swab; avoid rubbing vigorously.
- Rotate injection sites systematically with each daily injection to prevent lipodystrophy โ space injections at least 1 inch apart[13].
- Dispose of used syringes and needles immediately in a proper FDAโapproved sharps container[12].
Recommended Source
We recommend Pure Lab Peptides for highโpurity GHRP-2 in both vial sizes (5 mg and 10 mg).
Why Pure Lab Peptides?
- Highโpurity, thirdโpartyโtested peptides with batchโspecific Certificates of Analysis (COAs).
- Consistent, ISOโaligned handling and quality documentation.
- Reliable fulfillment with coldโchain integrity to preserve peptide stability.
- Transparent testing and verification processes for researchโgrade peptides.
- Multiple vial sizes to match different protocol needs and durations.
Important Note
This content is for educational purposes only and is not medical advice. GHRP-2 is for research use only. Not for human consumption. Always consult with qualified professionals before starting any peptide research protocol.
References
-
Domest Anim Endocrinol โ Effects of GHRP-2 on GH release โ Mechanism and receptor activation in swine
-
J Clin Endocrinol Metab โ GHRP-2 in GH-deficient children โ Eight months treatment with graded doses
-
Eur J Endocrinol โ Fiveโday GHRP-2: attenuation and IGFโI โ Response attenuation in healthy young men
-
Endocrine โ GH/IGFโ1 response to GHRP-2 in older adults โ Acute and chronic effects
-
Am J Menโs Health โ GH secretagogue raises IGFโ1 โ ~50% increase over 3 months in hypogonadal men
-
Sex Med Rev (PMC) โ Safety and efficacy of GH secretagogues โ Comprehensive review
-
Asian-Australas J Anim Sci โ Twiceโdaily GHRP-2 effects โ IGFโ1 and tachyphylaxis patterns
-
Sigma-Aldrich โ Peptide storage guidelines โ Lyophilized storage at โ20 ยฐC; reconstituted use within 4 weeks
-
Mountainside Medical โ Bacteriostatic Water guidelines โ Multiโdose vial guidelines; 28โday use recommendation
-
Usach I. et al. (2019) โ Subcutaneous injection technique โ Factors influencing pain and proper technique
-
MedlinePlus โ Subcutaneous (SQ) Injections โ Site selection, angle guidance, rotation best practices
-
CDC โ Vaccine Administration: Subcutaneous Route โ Clinical guidelines for angle, site selection, noโaspiration
-
Medicine LibreTexts โ Site rotation and lipodystrophy prevention โ Subcutaneous injection best practices
-
Pure Lab Peptides โ GHRP-2 product page โ Quality documentation and batch COAs

Reviews
There are no reviews yet.